| Autor: |
Caldarella C; Department of Bioimaging and Radiological Sciences, Institute of Nuclear Medicine, Università Cattolica del Sacro Cuore, Largo Gemelli 8, 00168 Rome, Italy., Treglia G, Isgrò MA, Treglia I, Giordano A |
| Jazyk: |
angličtina |
| Zdroj: |
International journal of molecular imaging [Int J Mol Imaging] 2012; Vol. 2012, pp. 175803. Date of Electronic Publication: 2012 Aug 10. |
| DOI: |
10.1155/2012/175803 |
| Abstrakt: |
Background and Aim. Fluorine-18-fluorodeoxyglucose positron emission tomography (FDG-PET) is well recognized as a powerful diagnostic tool in the initial staging of patients with multiple myeloma (MM). The aim of this paper is to perform a systematic review about the usefulness of FDG-PET or PET/CT in evaluating the response to treatment in patients with MM. Methods. The scientific literature about the role of FDG-PET or PET/CT in evaluating the response to treatment in patients affected by MM was systematically reviewed. Results. Ten studies about the role of FDG-PET or PET/CT in evaluating treatment response in MM were retrieved and discussed. Conclusions. FDG-PET or PET/CT seems to be helpful in assessing the response to treatment in patients with MM and in the evaluation of possible sites of recurrent or progressive disease. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
